The ventures arm of a top-20 U.S. health system sought support developing a go-to-market strategy for RWD-augmented biobank offerings
Client recognized that CapEx / OpEx associated with RWD / RWI solution builds did not align with its resources or organizational risk profile; client is focusing on executing Phase 1 of the outlined GTM strategy while building rapport and attracting potential partners for subsequent phases
12 weeks
U.S., EU
Pharma & Biotech
Voice-Of-Customer Research
Product Performance and Specification Mapping
Go-to-Market Strategy
Pricing Strategy
Competitive Analysis